Morling Financial Advisors LLC Grows Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Morling Financial Advisors LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 660 shares of the medical equipment provider’s stock after acquiring an additional 40 shares during the quarter. Morling Financial Advisors LLC’s holdings in Intuitive Surgical were worth $344,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp lifted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after buying an additional 210,363 shares in the last quarter. FMR LLC lifted its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Geode Capital Management LLC lifted its position in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after buying an additional 143,440 shares in the last quarter. Fisher Asset Management LLC lifted its position in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after buying an additional 86,488 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its position in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

ISRG opened at $482.61 on Tuesday. The stock has a market capitalization of $171.90 billion, a price-to-earnings ratio of 75.29, a PEG ratio of 5.85 and a beta of 1.43. The business has a fifty day moving average price of $570.48 and a 200 day moving average price of $531.79. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity

In other news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $533.18, for a total value of $260,725.02. Following the sale, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 13,309 shares of company stock valued at $7,611,004. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.